TOLBUTAMIDE TAB 500MG 500 MG
TOLBUTAMIDE : 500 MG · DIN 00156663 · PRO DOC LIMITEE
Health Canada status: CANCELLED POST MARKET
What is TOLBUTAMIDE TAB 500MG?
TOLBUTAMIDE TAB 500MG 500 MG contains TOLBUTAMIDE : 500 MG. It is listed in the Health Canada Drug Product Database under DIN 00156663, held by PRO DOC LIMITEE, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 13-Jul-2010. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is TOLBUTAMIDE TAB 500MG used for?
To control hyperglycemia in tolbutamide responsive diabetes mellitus of stable, mild, nonketosis prone, maturity onset or adult type which cannot be controlled by proper dietary management and exercise or when insulin therapy is not appropriate.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 00156663 |
|---|---|
| Brand name | TOLBUTAMIDE TAB 500MG |
| Generic / active ingredient | TOLBUTAMIDE : 500 MG |
| Manufacturer | PRO DOC LIMITEE |
| Strength | 500 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | A10BB03 TOLBUTAMIDE |
| AHFS class | 68:20.20 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 13-Jul-2010 |
| Original market date | 1962-12-31 00:00:00 |
How is it stored and handled?
Store at room temperature (15 to 30°C) in a tightly closed container.
How is it supplied?
bottles of 100 and 1000
What can be used instead?
Other Canadian products sharing ATC code A10BB03 TOLBUTAMIDE. 0 of 7 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| MOBENOL TABLETS 500MG | 500 MG | TABLET | CARTER-HORNER CORP. | CANCELLED POST MARKET | DIN 00013889 |
| NOVO-BUTAMIDE 500MG | 500 MG | TABLET | NOVOPHARM LIMITED | CANCELLED POST MARKET | DIN 00021849 |
| ORINASE 0.5GM | 500 MG | TABLET | HOECHST CANADA INC. | CANCELLED POST MARKET | DIN 00012602 |
| ORINASE 1GM | 1 G | TABLET | HOECHST CANADA INC. | CANCELLED POST MARKET | DIN 00012610 |
| TOLBUTAMIDE | 500 MG | TABLET | AA PHARMA INC | DORMANT | DIN 00312762 |
| TOLBUTAMIDE TAB 500MG | 500 MG | TABLET | DUCHESNAY INC | CANCELLED POST MARKET | DIN 00431168 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.